A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
fosbretablin 治疗晚期未分化甲状腺癌的 II 期试验以及基线血清可溶性细胞间粘附分子-1 与结果的相关性
期刊:Thyroid
影响因子:6.7
doi:10.1089/thy.2008.0321
Mooney Colin J, Nagaiah Govardhanan, Fu Pingfu, Wasman Jay K, Cooney Matthew M, Savvides Panos S, Bokar Joseph A, Dowlati Afshin, Wang Ding, Agarwala Sanjiv S, Flick Susan M, Hartman Paul H, Ortiz Jose D, Lavertu Pierre N, Remick Scot C
细胞生物学
甲状腺癌
Adhesion/ECM
肿瘤免疫
